Home Business Zydus Cadila gets USFDA nod for its migraine relief drug

Zydus Cadila gets USFDA nod for its migraine relief drug

By
Lucky Jain
-
494
0
(G.N.S) Dt. 12 New Delhi Drug firm Zydus Cadila today said it has received the final clearance from the US health regulator to market Zolmitriptan tablets, indicated for migraine patients. Zydus Cadila has received final approval from the US health regulator to market Zolmitriptan tablets, used to relieve headache, pain,

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   
New User Registration
*Required field

RELATED ARTICLESMORE FROM AUTHOR